These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 11555585

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Detailed methylation analysis of the glutathione S-transferase pi (GSTP1) gene in prostate cancer.
    Millar DS, Ow KK, Paul CL, Russell PJ, Molloy PL, Clark SJ.
    Oncogene; 1999 Feb 11; 18(6):1313-24. PubMed ID: 10022813
    [Abstract] [Full Text] [Related]

  • 23. Molecular detection of prostate cancer: a role for GSTP1 hypermethylation.
    Henrique R, Jerónimo C.
    Eur Urol; 2004 Nov 11; 46(5):660-9; discussion 669. PubMed ID: 15474280
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Methylation-specific PCR for detection of neoplastic DNA in biopsy washings.
    Goessl C, Müller M, Heicappell R, Krause H, Schostak M, Straub B, Miller K.
    J Pathol; 2002 Mar 11; 196(3):331-4. PubMed ID: 11857497
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Multigene methylation analysis for detection and staging of prostate cancer.
    Enokida H, Shiina H, Urakami S, Igawa M, Ogishima T, Li LC, Kawahara M, Nakagawa M, Kane CJ, Carroll PR, Dahiya R.
    Clin Cancer Res; 2005 Sep 15; 11(18):6582-8. PubMed ID: 16166436
    [Abstract] [Full Text] [Related]

  • 28. Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia.
    Esteller M, Corn PG, Urena JM, Gabrielson E, Baylin SB, Herman JG.
    Cancer Res; 1998 Oct 15; 58(20):4515-8. PubMed ID: 9788592
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. CpG island hypermethylation in cell-free serum DNA identifies patients with localized prostate cancer.
    Ellinger J, Haan K, Heukamp LC, Kahl P, Büttner R, Müller SC, von Ruecker A, Bastian PJ.
    Prostate; 2008 Jan 01; 68(1):42-9. PubMed ID: 18004747
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Methylation of multiple genes in prostate cancer and the relationship with clinicopathological features of disease.
    Singal R, Ferdinand L, Reis IM, Schlesselman JJ.
    Oncol Rep; 2004 Sep 01; 12(3):631-7. PubMed ID: 15289848
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Study on the diagnosis of prostatic cancer by detecting methylated GSTP1 promotor region from the urinary samples].
    Kato T.
    Hokkaido Igaku Zasshi; 2005 Mar 01; 80(2):251-61. PubMed ID: 15868711
    [No Abstract] [Full Text] [Related]

  • 40. Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.
    Dulaimi E, Hillinck J, Ibanez de Caceres I, Al-Saleem T, Cairns P.
    Clin Cancer Res; 2004 Sep 15; 10(18 Pt 1):6189-93. PubMed ID: 15448006
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.